FDA warning: This popular anxiety drug was just recalled

Here’s everything you need to know.

EUR1.3M funding for MastCURe's innovative mast-cell directed therapies

MastCURe, a high-profile research consortium, has been awarded EUR1.3M in funding from the Eureka Eurostars program. The collaboration comprising Allegria Therapeutics, Cube Biotech, and the ...
IEEE

Rethinking Multiple Instance Learning for Whole Slide Image Classification: A Bag-Level Classifier is a Good Instance-Level Teacher

Abstract: Multiple Instance Learning (MIL) has demonstrated promise in Whole Slide Image (WSI) classification. However, a major challenge persists due to the high computational cost associated with ...
Greek City Times

FDA to Review 12 Peptides After Reversing High-Risk Classification

The FDA is set to review 12 peptides after reversing their high-risk classification, marking a shift toward regulated access ...
TMCnet

Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong enrollment velocity and significant unmet medical need ...
Scientific Research Publishing

Analytical Chemistry of New Psychoactive Substances: Methods, Applications and Future Prospects ()

New psychoactive substances (NPS) are a class of artificially designed and synthesized chemical substances designed to mimic the pharmacological effects of traditional drugs. They are characterized by ...